Albert Cortés

Safety and efficacy of CD19 CAR-T therapy in patients with DLBCL and GI involvement. Happy to share these results with @app1279 and @MichaelDJain

Feeling very happy and fulfilled with the support of my @hematoclinicbcn colleagues at #ASH23 Gràcies 🥰 #ARI0002h #ARI001

@cjimenezvicente Felicitats Carlos 😁

Venetoclax + hypomethylating agents can eradicate MRD in AML with mutated NPM1 and CBF rearrangement! 💥Check it out at #LeukemiaResearch sciencedirect.com/science/articl…

🏆@oriol_pich ha guanyat el #PremiSCB2023 a al #JoveInvestigador per la tesi “The role of mutational processes in the evolution of somatic tissues and malignancy” @UPFBarcelona @UPFBiomed #NitBio2023 #PremisSCB2023

Our latest from @SwantonLab out in @Nature, where we describe how air pollutants promote lung cancer 🥳 congrats to everybody involved, especially the superstars @WillHilliam @LimEmilia @DrClareWeeden 🎸 So grateful to have been a part of this project!!

A new model to predict survival after low-intensity chemoRx in older #AML published by Dr. Koji Sasaki of @MDAndersonNews #Leukemia, @JournalCancer online acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #leusm

👨‍🎓Enhorabuena al Dr.Valentin Ortiz-Maldonado @ValentinOrtizMD, por la fantástica disertación de su Tesis Doctoral titulada “Seguridad y eficacia de Varnicel en Sx linfoproliferativos CD19 positivos”. 👏 Felicidades por este gran logro 👏 @hospitalclinic @immunoclinicbcn

We have been two great and intensive days at Montseny for our 2022 Retreat. We bring home lots of new knowledge and fun, and specially a very nice and strong sense of belonging to a great group of people doing great science.

We are delighted to share our review ‘The translational challenges of precision oncology’ in @Cancer_Cell, co-authored with @cbailey_58 under the guidance of @CharlesSwanton and our team 💪🏾 @tbkwatkins @ZaccaSimo @MariamJHanjani shorturl.at/lnswJ 1/11

@AMartinezRocaMD @paraulogic Brunzit ;)

Los del @paraulogic hoy se han pasado tres pueblos 💆🏽‍♀️ #help

👏👏3 charlas fantásticas de @ValentinOrtizMD sobre nuestro ARI-0001 en #leusm y #LLC👏👏 #Hemato2021 @hospitalclinic

Excelente revisión por @nilalbiol The road to chemotherapy-free treatment in #CLL Current Opinion in Oncology journals.lww.com/co-oncology/Ab…

Published in Cancer J. by @Wolters_Kluwer!!! Autoimmune cytopenia (AIC) is a common feature in CLL (up to 10-15% of patients). In this review, Carol Moreno and I focus on the prognostic impact of AIC in CLL and their management, including novel therapies. journals.lww.com/journalppo/Abs…

Ten slides that summarize current diagnosis and treatment of multiple myeloma, smoldering myeloma, and MGUS. For clinical practice or the boards. #medtwitter 1. Diagnostic Criteria and Disease Definitions

@oriol_pich @nlbigas @abel_gonzalezp @fmuinos sheded some light on the genesis of therapy related AML by proving platinum based drugs can cause a direct and clonal damage to myeloid blasts. Happy to have been part of this with @hematosantpau . Thanks mate @oriol_pich 😘

Safety and efficacy of CD19 CAR-T therapy in patients with DLBCL and GI involvement. Happy to share these results with @app1279 and @MichaelDJain

@mcorrochanof @hematosantpau 😍😍 la mejor!!!

@ImLucia_GP 😍😍 el placer es mío!

Y no puedo esconder el orgullo de resi pequeña hacia @a_cortesbu 🥰

Motivación contagiosa. ¡Habeis estado de 10! @hematosantpau #MIR #inmunoterapia